These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 11277192

  • 1. Evaluation of the safety of an abbreviated course of injections of allergen extracts (rush immunotherapy) for the treatment of dogs with atopic dermatitis.
    Mueller RS, Bettenay SV.
    Am J Vet Res; 2001 Mar; 62(3):307-10. PubMed ID: 11277192
    [Abstract] [Full Text] [Related]

  • 2. Long-term effects of intralymphatic immunotherapy (ILIT) on canine atopic dermatitis.
    Timm K, Mueller RS, Nett-Mettler CS.
    Vet Dermatol; 2018 Apr; 29(2):123-e49. PubMed ID: 29327474
    [Abstract] [Full Text] [Related]

  • 3. Effectiveness of regionally-specific immunotherapy for the management of canine atopic dermatitis.
    Plant JD, Neradilek MB.
    BMC Vet Res; 2017 Jan 05; 13(1):4. PubMed ID: 28056956
    [Abstract] [Full Text] [Related]

  • 4. Use of immunostimulatory liposome-nucleic acid complexes in allergen-specific immunotherapy of dogs with refractory atopic dermatitis - a pilot study.
    Mueller RS, Veir J, Fieseler KV, Dow SW.
    Vet Dermatol; 2005 Feb 05; 16(1):61-8. PubMed ID: 15725107
    [Abstract] [Full Text] [Related]

  • 5. Rush allergen specific immunotherapy protocol in feline atopic dermatitis: a pilot study of four cats.
    Trimmer AM, Griffin CE, Boord MJ, Rosenkrantz WS.
    Vet Dermatol; 2005 Oct 05; 16(5):324-9. PubMed ID: 16238812
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of rush immunotherapy with alum-precipitated allergens in canine atopic dermatitis.
    Hobi S, Mueller RS.
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 2014 Oct 05; 42(3):167-73. PubMed ID: 24920143
    [Abstract] [Full Text] [Related]

  • 7. The safety of rush immunotherapy in the management of canine atopic dermatitis-230 cases.
    Weitzer T, Mueller R.
    Vet Dermatol; 2023 Oct 05; 34(5):385-392. PubMed ID: 37157908
    [Abstract] [Full Text] [Related]

  • 8. Update on Allergen Immunotherapy.
    Mueller RS.
    Vet Clin North Am Small Anim Pract; 2019 Jan 05; 49(1):1-7. PubMed ID: 30227970
    [Abstract] [Full Text] [Related]

  • 9. Results of allergen-specific immunotherapy in 117 dogs with atopic dermatitis.
    Schnabl B, Bettenay SV, Dow K, Mueller RS.
    Vet Rec; 2006 Jan 21; 158(3):81-5. PubMed ID: 16428661
    [Abstract] [Full Text] [Related]

  • 10. Requirement for additional treatment for dogs with atopic dermatitis undergoing allergen-specific immunotherapy.
    Colombo S, Hill PB, Shaw DJ, Thoday KL.
    Vet Rec; 2007 Jun 23; 160(25):861-4. PubMed ID: 17586789
    [Abstract] [Full Text] [Related]

  • 11. A randomised, double-blinded comparison between subcutaneous rush and intralympathic allergen immunotherapy induction in atopic dogs.
    Mueller RS, Zablotski Y, Baumann K, Boehm T, Kasper B, Klinger C, Monke M, Udraite-Vovk L, Weitzer T, Gedon NKY.
    Vet Dermatol; 2023 Apr 23; 34(2):91-98. PubMed ID: 36424528
    [Abstract] [Full Text] [Related]

  • 12. Quantitation of canine regulatory T cell populations, serum interleukin-10 and allergen-specific IgE concentrations in healthy control dogs and canine atopic dermatitis patients receiving allergen-specific immunotherapy.
    Keppel KE, Campbell KL, Zuckermann FA, Greeley EA, Schaeffer DJ, Husmann RJ.
    Vet Immunol Immunopathol; 2008 Jun 15; 123(3-4):337-44. PubMed ID: 18423890
    [Abstract] [Full Text] [Related]

  • 13. A systematic review of allergen immunotherapy, a successful therapy for canine atopic dermatitis and feline atopic skin syndrome.
    Mueller RS.
    J Am Vet Med Assoc; 2023 Jun 01; 261(S1):S30-S35. PubMed ID: 36940185
    [Abstract] [Full Text] [Related]

  • 14. Allergen-specific immunotherapy induces Th1 shift in dogs with atopic dermatitis.
    Shida M, Kadoya M, Park SJ, Nishifuji K, Momoi Y, Iwasaki T.
    Vet Immunol Immunopathol; 2004 Nov 01; 102(1-2):19-31. PubMed ID: 15451612
    [Abstract] [Full Text] [Related]

  • 15. The ACVD task force on canine atopic dermatitis (XXIV): allergen-specific immunotherapy.
    Griffin CE, Hillier A.
    Vet Immunol Immunopathol; 2001 Sep 20; 81(3-4):363-83. PubMed ID: 11553398
    [Abstract] [Full Text] [Related]

  • 16. Effect of hyposensitization on atopic dermatitis in dogs.
    Willemse A, Van den Brom WE, Rijnberk A.
    J Am Vet Med Assoc; 1984 May 15; 184(10):1277-80. PubMed ID: 6376442
    [Abstract] [Full Text] [Related]

  • 17. Rush sublingual immunotherapy in canine atopic dermatitis: a prospective pilot study.
    Fujimura M, Ishimaru H.
    Pol J Vet Sci; 2016 May 15; 19(1):3-6. PubMed ID: 27096781
    [Abstract] [Full Text] [Related]

  • 18. Proof of concept of the preventive efficacy of high-dose recombinant mono-allergen immunotherapy in atopic dogs sensitized to the Dermatophagoides farinae allergen Der f 2.
    Olivry T, Paps JS, Dunston SM.
    Vet Dermatol; 2017 Apr 15; 28(2):183-e40. PubMed ID: 28261915
    [Abstract] [Full Text] [Related]

  • 19. [Intralymphatic immunotherapy: An effective and safe alternative route for canine atopic dermatitis].
    Fischer N, Rostaher A, Favrot C.
    Schweiz Arch Tierheilkd; 2016 Sep 15; 158(9):646-652. PubMed ID: 27655164
    [Abstract] [Full Text] [Related]

  • 20. Results of allergen-specific immunotherapy in atopic dogs with Malassezia hypersensitivity: a retrospective study of 16 cases.
    Åberg L, Varjonen K, Åhman S.
    Vet Dermatol; 2017 Dec 15; 28(6):633-e157. PubMed ID: 28748560
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.